Gold tier: mechanically validated evidence, with its primary source.
696 evidence items · page 20 / 28
2.4 %The hybridization rate between An. coluzzii and An. gambiae in Senegal was 2.4% to 4.4%.
Sénégalpaludismeobserved 2018published 2020Characterisation of the Swarming Behavior of An. coluzzii and An. Gambiae Populations fromeurope_pmcDOI 10.21203/rs.3.rs-26086/v1
15.8 parasites per μLPendant la saison des pluies, la parasitémie médiane atteignait 15,8 parasites par μL chez les participants âgés de 15 à 19 ans.
SénégalpaludismeHAL · Unilimdocument of 117 observations
19.6 %Au Sénégal, le diagnostic biologique de la drépanocytose est établi à partir de symptômes cliniques dans 19,6 % des cas.
SénégaldrépanocytoseHAL · Unilimdocument of 857 observations
56 %Parmi les 100 participants inclus dans l’étude, 56 % avaient le génotype SS (HbSS), 21 % le génotype AS (HbAS) et 23 % le génotype normal (HbAA).
SénégaldrépanocytoseHAL · Unilimdocument of 30 observations
0.32 per_100_person-yearsThe mortality rate of life-threatening bleeding was 0.32 death per 100 person-years in a cohort of 274 people with hemophilia in Senegal.
Sénégallife-threatening bleedingpublished 2022Hematology (Amsterdam, Netherlands)europe_pmcdocument of 21 observationsDOI 10.1080/16078454.2022.2047286
20 yearsPatients living with sickle cell anemia had a median age of 20 years (range 4 to 57) with a female sex frequency of 53.21%.
Sénégaldrépanocytosepublished 2022PloS oneeurope_pmcdocument of 9 observationsDOI 10.1371/journal.pone.0273745
112,866 DALYsStrategy 19, using Gardasil 9 with 90% coverage, achieved the greatest health benefit, averting 112,866 DALYs.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
612 patients612 sickle cell disease patients and 149 healthy controls were included in the CADRE study in Cameroon, Mali, and Senegal.
Cameroun · Mali · SénégaldrépanocytoseHAL · Unilimdocument of 2 observations
14 %Une minorité de 14 % des élèves estime être mieux traitée que leurs camarades.
SénégaldrépanocytoseHAL · Unilimdocument of 857 observations
70 %In the base-case analysis, a single dose of the HPV vaccine was assumed to provide 70% to 100% of the total efficacy associated with two doses.
Sénégalinfection à HPVHAL · Unilimdocument of 111 observations
10 yearsAprès 10 ans de mise en œuvre de la chimio-prévention saisonnière du paludisme (SMC) au Sénégal, la circulation de Plasmodium falciparum prospère chez les individus immédiatement au-dessus du seuil d’âge éligible à la SMC et jusqu’à 15 ans plus âgés.
SénégalpaludismeHAL · Unilimdocument of 117 observations
73.9 %Hyperleukocytosis greater than 10000 leucocytes/mm³ was found in 34 patients (73.9%) with sickle cell disease SS.
Sénégaldrépanocytoseobserved 2015-2017published 2017The Pan African medical journaleurope_pmcdocument of 9 observations
3.4 %L’enquête STEPS de l’ANSD réalisée en 2015 a montré une prévalence du diabète de 3,4 % au Sénégal.
Sénégaldiabète (non précisé)observed 2015HAL · Unilimdocument of 857 observations
90.01 %At the basal state, SS subjects had a higher sickle cell rate of 90.01% compared to AS subjects with a sickle cell rate of 73.15%.
SénégaldrépanocytoseHAL · Unilimdocument of 19 observations
149.4 per_100000The annual rate of cervical cancer deaths per 100,000 females in Senegal was 149.4 for the 80–84 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
7.9 %Hypertension was present in 7.9% of patients with extrapulmonary tuberculosis in the study conducted at Fann National University Hospital and Hôpital Principal de Dakar, Senegal, from March 1, 2019, to February 29, 2020.
Sénégalhypertension artérielle · tuberculoseobserved 2019-03-01 to 2020-02-29HAL · Unilimdocument of 12 observations
17 %Les maladies cardiovasculaires représentent 17 % des décès au Sénégal.
Sénégalmaladies cardiovasculairesHAL · Unilimdocument of 857 observations
74 %With a median follow-up of 11.4 months, the 24-month progression-free survival rate was 74%.
SénégalDLBCLpublished 2025EJHaemeurope_pmcdocument of 5 observations
39.33 %Proteinuria was observed in 39.33% of patients living with sickle cell anemia versus 4.62% in controls.
Sénégaldrépanocytose · proteinuriapublished 2022PloS oneeurope_pmcdocument of 9 observationsDOI 10.1371/journal.pone.0273745
3 %Les maladies respiratoires chroniques représentent 3 % des décès au Sénégal.
Sénégalmaladies respiratoires chroniquesHAL · Unilimdocument of 857 observations
72 %72 % des drépanocytaires sont informés que la drépanocytose n'est pas contagieuse.
SénégaldrépanocytoseHAL · Unilimdocument of 857 observations
580 IU/kg/yearConsumption was 580 IU/kg/year versus 1254.6 IU/kg/year before and after prophylaxis, respectively.
Sénégalhaemophiliapublished 2023Hematology, transfusion and cell therapyeurope_pmcdocument of 11 observations
105.2 per_100000The annual rate of cervical cancer cases per 100,000 females in Senegal was 105.2 for the 60–64 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
La prévalence du Plasmodium falciparum était de 10–15 % lors de l'enquête T0, de 5–10 % lors de T1, et de 5 % lors de T3.
SénégalpaludismeHAL · Unilimdocument of 117 observations
0.001 piThe genetic diversity (π) of Pf41 sequences was 0.00144 ± 0.00022.
Sénégalpaludismepublished 2025Scientific reportseurope_pmcdocument of 3 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.